BENIGN HEMATOLOGY PROGRAM

Bleeding Disorders Clinical Research

1. El Hasbani G, Taher AT. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia? Med Hypotheses. 2021 Jul;152:110621. doi: 10.1016/j.mehy.2021.110621. Epub 2021 Jun 4. PMID: 34116360; PMCID: PMC8176888.

2. Moukalled NM, Hashash JG, Taher AT. Inflammatory Bowel Disease: An Indication to Screen for Thrombophilia? Diseases. 2022 Feb 23;10(1):14. doi: 10.3390/diseases10010014. PMID: 35323181; PMCID: PMC8947449.

3. Kfoury E, Taher A, Saghieh S, Otrock ZK, Mahfouz R. The impact of inherited thrombophilia on surgery: a factor to consider before transplantation? Mol Biol Rep. 2009 May;36(5):1041-51. doi: 10.1007/s11033-008-9278-4. Epub 2008 May 31. PMID: 18516702.

4. Taher A, Al Mahmasani L, Aadra A, Yazbeck P, Saad GA, Nasr F, Habib R, Chalfoun A, Haddad F. Assessment of Lebanese healthcare professionals’ awareness on acquired haemophilia: a cross-sectional study. Hematology. 2021 Dec;26(1):83-87. doi: 10.1080/16078454.2020.1869885. PMID: 33427128.

5. Moukalled NM, Zakhia El-Doueihi PT, Salem RJ, Taher AT. Drug related bleeding as a cause of emergency department visits; a Lebanese tertiary care center experience. Eur J Intern Med. 2018 Sep;55:e10-e12. doi: 10.1016/j.ejim.2018.06.010. Epub 2018 Jun 14. PMID: 29910101.

6. Tamim H, Habbal M, Saliba A, Musallam K, Al-Taki M, Hoballah J, Jamali S, Taher A. Preoperative INR and postoperative major bleeding and mortality: A retrospective cohort study. J Thromb Thrombolysis. 2016 Feb;41(2):301-11. doi: 10.1007/s11239-015-1235-1. PMID: 26036228.

7. Hoteit R, Taher A, Nassar R, Otrock Z, Halawi R, Mahfouz RA. Frequency of triple mutations involving factor V, prothrombin, and methylenetetrahydrofolate reductase genes among patients referred for molecular thrombophilia workup in a tertiary care center in Lebanon. Genet Test Mol Biomarkers. 2012 Mar;16(3):223-5. doi: 10.1089/gtmb.2011.0114. Epub 2011 Oct 24. PMID: 22023246.

8. Musallam KM, Saad GS, Majdalani MN, Muwakkit SA, Bou-Khalil PK, Aoun EG, Sawaya RA, Khalil I, Taher AT. Use of recombinant activated factor VII for intractable bleeding in patients without hemophilia: A developing country tertiary care center’s experience. Clin Appl Thromb Hemost. 2010 Dec;16(6):658-62. doi: 10.1177/1076029609343448. Epub 2009 Aug 10. PMID: 19671562.

9. Kaafarani H, Taher A, Haddad MC, Haidar A, Mourad FH. Spontaneous intracholecystic bleeding in a patient with von Willebrand’s disease. Gastrointest Endosc. 2003 Nov;58(5):809-11. doi: 10.1016/s0016-5107(03)02145-x. PMID: 14997895.

10. El Accaoui R, Isma’eel H, Khalil PB, Taher A. A review of the off-label use of recombinant activated factor VII in a developing country tertiary care center. Blood Coagul Fibrinolysis. 2006 Nov;17(8):647-50. doi: 10.1097/01.mbc.0000252599.32648.35. PMID: 17102651.